In our in vitro study, indirubin was found to increase the PD1 expression on CD4+ T cells of ITP patients, and induce the phosphorylation of PTEN, with the downstream dephosphorylation of p‐AKT and p‐mTOR. The gene discussed is MTOR; the disease is autoimmune thrombocytopenic purpura.